共 23 条
[1]
Current pharmacological therapies for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis[J]. Yoshihisa Takahashi,Keiichiro Sugimoto,Hiroshi Inui,Toshio Fukusato.World Journal of Gastroenterology. 2015(13)
[2]
Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial[J]. Shira Zelber-Sagi,Assaf Buch,Hanny Yeshua,Nahum Vaisman,Muriel Webb,Gil Harari,Ofer Kis,Naomi Fliss-Isakov,Elena Izkhakov,Zamir Halpern,Erwin Santo,Ran Oren,Oren Shibolet.World Journal of Gastroenterology. 2014(15)
[4]
Moderate to vigorous physical activity volume is an important factor for managing nonalcoholic fatty liver disease: A retrospective study[J] . Sechang Oh,Takashi Shida,Kazumasa Yamagishi,Kiyoji Tanaka,Rina So,Takehiko Tsujimoto,Junichi Shoda.Hepatology . 2015 (4)
[6]
Nonalcoholic Steatohepatitis is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the U.S[J] . Robert J. Wong,Maria Aguilar,Ramsey Cheung,Ryan B. Perumpail,Stephen A. Harrison,Zobair M. Younossi,Aijaz Ahmed.Gastroenterology . 2014
[7]
A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver;Should we care?[J] . Ebenezer T. Oni,Arthur S. Agatston,Michael J. Blaha,Jonathan Fialkow,Ricardo Cury,Andrei Sposito,Raimund Erbel,Ron Blankstein,Ted Feldman,Mouaz H. Al-Mallah,Raul D. Santos,Matthew J. Budoff,Khurram Nasir.Atherosclerosis . 2013 (2)
[9]
Exercise Prescription in the Treatment of Type 2 Diabetes Mellitus[J] . Ciara O’Hagan,Giuseppe Vito,Colin A. G. Boreham.Sports Medicine . 2013 (1)
[10]
Non‐alcoholic fatty liver disease ( NAFLD ) is associated with low level of physical activity: a population‐based study[J] . L. Gerber,M. Otgonsuren,A. Mishra,C. Escheik,A. Birerdinc,M. Stepanova,Z. M. Younossi.Aliment Pharmacol Ther . 2012 (8)